Piperine Enhances Antimalarial Activity of Methyl Gallate and Palmatine Combination
- PMID: 38705947
- DOI: 10.1007/s11686-024-00850-x
Piperine Enhances Antimalarial Activity of Methyl Gallate and Palmatine Combination
Abstract
Purpose: Artemisinin combination therapies, the first-line antimalarials in Nigeria, have reportedly suffered multiple failures in malaria treatment, hence the search for novel combination of other compounds. Methyl gallate and palmatine have been reported to exhibit antiplasmodial activities but the antimalarial activity of their combination has not been evaluated. Therefore, the evaluation of the combination of methyl gallate and palmatine for antimalarial activity in vitro and in vivo in the presence of piperine was carried out.
Materials and methods: The inhibitory potential of methyl gallate and palmatine combination on β-hematin (hemozoin) formation was studied in vitro. Also, the antimalarial activity of methyl gallate and palmatine combination with/without a bioenhancer (piperine) was evaluated in Plasmodium berghei NK65-infected mice.
Results: Methyl gallate and palmatine in the ratio 3:2 acted synergistically in vitro and had the highest inhibitory effect (IC50 = 0.73 µg/mL) on β-hematin (hemozoin) formation. The 3:2 combination of methyl gallate and palmatine exhibited no antimalarial activity in vivo in the absence of piperine but caused reduction in parasitemia that exceeded 40% in the presence of piperine at the dose of 25 mg/kg body weight on days 6 and 8 post-inoculation in mice.
Conclusion: The 3:2 combination of methyl gallate and palmatine in the presence of piperine exhibited antimalarial activity in vivo, possibly by synergistic inhibition of hemozoin formation which may cause accumulation of haem within the food vacuole of Plasmodium spp. and its death.
Keywords: Antimalarial; Bioenhancer; Drug combination; Methyl gallate; Palmatine; Piperine.
© 2024. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
References
-
- WHO (2020) World malaria report 2020: 20 years of global progress and challenges. World Health Organization
-
- WHO (2018) World Malaria Report 2018. Geneva
-
- Schlitzer M (2008) Antimalarial drugs—what is in use and what is in the pipeline. Arch Pharm (Weinheim) 341:149–163. https://doi.org/10.1002/ardp.200700184 - DOI - PubMed
-
- Beshir K, Sutherland CJ, Merinopoulos I, Durrani N, Leslie T, Rowland M, Hallett RL (2010) Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76. Antimicrob Agents Chemother 54:3714–3716. https://doi.org/10.1128/aac.00358-10 - DOI - PubMed - PMC
-
- Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, Eam R (2017) A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype–genotype association study. Lancet Infect Dis 17:174–183. https://doi.org/10.1016/S1473-3099(16)30415-7 - DOI - PubMed - PMC
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
